Related Experiment Videos
Botox induced muscle paralysis rapidly degrades bone
Sarah E Warner1, David A Sanford, Blair A Becker
1Department of Orthopaedics and Sports Medicine, University of Washington, 325 Ninth Ave, Box 359798, Seattle, WA 98104-2499, USA.
Bone
|September 28, 2005
Summary
Muscle paralysis from botulinum toxin A (Botox) significantly degrades bone and muscle mass in mice. This study establishes a new model to investigate neuromuscular effects on bone health.
Area of Science:
- * Bone biology and neuromuscular research.
- * Translational research in musculoskeletal health.
Background:
- * The relationship between muscle function and bone homeostasis is not well understood.
- * Neuromuscular disorders and treatments can impact bone health.
Purpose of the Study:
- * To develop and validate a novel murine model of unilateral hindlimb muscle paralysis.
- * To investigate the effects of transient muscle paralysis on bone and muscle integrity.
Main Methods:
- * Induced transient hindlimb muscle paralysis using botulinum toxin A (Botox) in female C57BL/6 mice.
- * Assessed gait, muscle mass (wet mass), and bone structure (micro-CT) of femur and tibia.
- * Compared injected limbs with saline-injected controls and contralateral limbs.
Main Results:
- * Botox injections led to significant muscle mass reduction (-47.3% quadriceps, -59.7% calf).
- * Micro-CT revealed substantial bone loss: -43.2% distal femur BV/TV, -54.3% proximal tibia BV/TV, -14.6% tibia cortical bone.
- * Bone loss appeared primarily driven by increased bone resorption, with some systemic effects noted.
Conclusions:
- * Neuromuscular function critically mediates bone homeostasis.
- * The developed Botox-induced paralysis model effectively demonstrates muscle and bone degradation.
- * Highlights the need to monitor bone loss in patients receiving neuromuscular inhibitors.